High numbers of intratumoral Nrp1+ Tregs are associated with poor prognosis and outcomes in melanoma and head and neck squamous cell carcinoma (75), as they are driving a shift towards an IFNγ-insensitive immunosuppressive phenotype for CD8+ cells that is conducive to tumor growth. Here, NRP1 is linked to melanoma.